Annual Retained Earnings
-$1.41 B
-$25.09 M-1.81%
31 December 2023
Summary:
Rigel Pharmaceuticals annual retained earnings is currently -$1.41 billion, with the most recent change of -$25.09 million (-1.81%) on 31 December 2023. During the last 3 years, it has fallen by -$101.58 million (-7.78%). RIGL annual retained earnings is now -4818.24% below its all-time high of -$28.62 million, reached on 31 December 1999.RIGL Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.40 B
+$12.42 M+0.88%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly retained earnings is currently -$1.40 billion, with the most recent change of +$12.42 million (+0.88%) on 30 September 2024. Over the past year, it has increased by +$3.88 million (+0.28%). RIGL quarterly retained earnings is now -2501.76% below its all-time high of -$53.98 million, reached on 31 December 2000.RIGL Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.8% | +0.3% |
| 3 y3 years | -7.8% | -7.9% |
| 5 y5 years | -16.4% | -11.6% |
RIGL Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.8% | at low | -7.9% | +0.9% |
| 5 y | 5 years | -16.4% | at low | -11.9% | +0.9% |
| alltime | all time | -4818.2% | at low | -2501.8% | +0.9% |
Rigel Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.40 B(-0.9%) |
| June 2024 | - | -$1.42 B(+0.1%) |
| Mar 2024 | - | -$1.42 B(+0.6%) |
| Dec 2023 | -$1.41 B(+1.8%) | -$1.41 B(-0.1%) |
| Sept 2023 | - | -$1.41 B(+0.4%) |
| June 2023 | - | -$1.40 B(+0.5%) |
| Mar 2023 | - | -$1.40 B(+1.0%) |
| Dec 2022 | -$1.38 B(+4.4%) | -$1.38 B(-0.1%) |
| Sept 2022 | - | -$1.38 B(+1.4%) |
| June 2022 | - | -$1.36 B(+1.0%) |
| Mar 2022 | - | -$1.35 B(+2.1%) |
| Dec 2021 | -$1.32 B(+1.4%) | -$1.32 B(+1.7%) |
| Sept 2021 | - | -$1.30 B(+1.6%) |
| June 2021 | - | -$1.28 B(+1.1%) |
| Mar 2021 | - | -$1.27 B(-3.0%) |
| Dec 2020 | -$1.31 B(+2.3%) | -$1.31 B(+1.5%) |
| Sept 2020 | - | -$1.29 B(+1.1%) |
| June 2020 | - | -$1.27 B(+1.4%) |
| Mar 2020 | - | -$1.25 B(-1.7%) |
| Dec 2019 | -$1.28 B(+5.5%) | -$1.28 B(+1.4%) |
| Sept 2019 | - | -$1.26 B(+0.9%) |
| June 2019 | - | -$1.25 B(+1.7%) |
| Mar 2019 | - | -$1.23 B(+1.5%) |
| Dec 2018 | -$1.21 B(+6.2%) | -$1.21 B(-0.3%) |
| Sept 2018 | - | -$1.21 B(+2.0%) |
| June 2018 | - | -$1.19 B(+2.2%) |
| Mar 2018 | - | -$1.16 B(+2.1%) |
| Dec 2017 | -$1.14 B(+7.4%) | -$1.14 B(+2.3%) |
| Sept 2017 | - | -$1.11 B(+1.6%) |
| June 2017 | - | -$1.10 B(+1.8%) |
| Mar 2017 | - | -$1.08 B(+1.4%) |
| Dec 2016 | -$1.06 B(+7.0%) | -$1.06 B(+1.5%) |
| Sept 2016 | - | -$1.05 B(+2.2%) |
| June 2016 | - | -$1.02 B(+1.3%) |
| Mar 2016 | - | -$1.01 B(+1.8%) |
| Dec 2015 | -$991.65 M(+5.5%) | -$991.65 M(+1.3%) |
| Sept 2015 | - | -$978.96 M(+0.7%) |
| June 2015 | - | -$972.29 M(+1.5%) |
| Mar 2015 | - | -$958.38 M(+1.9%) |
| Dec 2014 | -$940.18 M(+10.7%) | -$940.18 M(+2.4%) |
| Sept 2014 | - | -$917.91 M(+2.3%) |
| June 2014 | - | -$896.97 M(+2.9%) |
| Mar 2014 | - | -$871.58 M(+2.6%) |
| Dec 2013 | -$849.27 M(+11.7%) | -$849.27 M(+2.0%) |
| Sept 2013 | - | -$832.41 M(+2.9%) |
| June 2013 | - | -$808.59 M(+2.9%) |
| Mar 2013 | - | -$785.82 M(+3.4%) |
| Dec 2012 | -$760.25 M | -$760.25 M(+3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | -$734.77 M(+3.6%) |
| June 2012 | - | -$709.32 M(+3.6%) |
| Mar 2012 | - | -$684.58 M(+3.5%) |
| Dec 2011 | -$661.41 M(+14.9%) | -$661.41 M(+4.1%) |
| Sept 2011 | - | -$635.62 M(+2.9%) |
| June 2011 | - | -$617.69 M(+3.6%) |
| Mar 2011 | - | -$596.22 M(+3.6%) |
| Dec 2010 | -$575.43 M(-6.2%) | -$575.43 M(-5.5%) |
| June 2010 | - | -$608.63 M(-4.3%) |
| Mar 2010 | - | -$635.66 M(+3.6%) |
| Dec 2009 | -$613.32 M(+22.2%) | -$613.32 M(+4.3%) |
| Sept 2009 | - | -$588.23 M(+4.7%) |
| June 2009 | - | -$561.58 M(+5.6%) |
| Mar 2009 | - | -$531.70 M(+6.0%) |
| Dec 2008 | -$501.78 M(+35.8%) | -$501.78 M(+7.1%) |
| Sept 2008 | - | -$468.41 M(+8.8%) |
| June 2008 | - | -$430.72 M(+8.6%) |
| Mar 2008 | - | -$396.69 M(+7.4%) |
| Dec 2007 | -$369.43 M(+25.2%) | -$369.43 M(+5.4%) |
| Sept 2007 | - | -$350.43 M(+5.7%) |
| June 2007 | - | -$331.49 M(+6.2%) |
| Mar 2007 | - | -$312.24 M(+5.8%) |
| Dec 2006 | -$295.16 M(+14.6%) | -$295.16 M(+5.5%) |
| Sept 2006 | - | -$279.70 M(+4.2%) |
| June 2006 | - | -$268.32 M(+0.9%) |
| Mar 2006 | - | -$265.99 M(+3.3%) |
| Dec 2005 | -$257.52 M(+21.3%) | -$257.52 M(+3.6%) |
| Sept 2005 | - | -$248.63 M(+5.5%) |
| June 2005 | - | -$235.72 M(+5.5%) |
| Mar 2005 | - | -$223.43 M(+5.3%) |
| Dec 2004 | -$212.27 M(+36.1%) | -$212.27 M(+7.5%) |
| Sept 2004 | - | -$197.54 M(+8.9%) |
| June 2004 | - | -$181.40 M(+7.3%) |
| Mar 2004 | - | -$169.06 M(+8.4%) |
| Dec 2003 | -$156.01 M(+35.9%) | -$156.01 M(+8.2%) |
| Sept 2003 | - | -$144.15 M(+8.3%) |
| June 2003 | - | -$133.08 M(+8.5%) |
| Mar 2003 | - | -$122.61 M(+6.8%) |
| Dec 2002 | -$114.81 M(+47.6%) | -$114.81 M(+7.6%) |
| Sept 2002 | - | -$106.74 M(+10.5%) |
| June 2002 | - | -$96.60 M(+12.1%) |
| Mar 2002 | - | -$86.16 M(+10.8%) |
| Dec 2001 | -$77.78 M(+44.1%) | -$77.78 M(+8.5%) |
| Sept 2001 | - | -$71.67 M(+9.5%) |
| June 2001 | - | -$65.45 M(+12.6%) |
| Mar 2001 | - | -$58.14 M(+7.7%) |
| Dec 2000 | -$53.98 M(+88.6%) | -$53.98 M |
| Dec 1999 | -$28.62 M | - |
FAQ
- What is Rigel Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual retained earnings year-on-year change?
- What is Rigel Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly retained earnings year-on-year change?
What is Rigel Pharmaceuticals annual retained earnings?
The current annual retained earnings of RIGL is -$1.41 B
What is the all time high annual retained earnings for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual retained earnings is -$28.62 M
What is Rigel Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, RIGL annual retained earnings has changed by -$25.09 M (-1.81%)
What is Rigel Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of RIGL is -$1.40 B
What is the all time high quarterly retained earnings for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly retained earnings is -$53.98 M
What is Rigel Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, RIGL quarterly retained earnings has changed by +$3.88 M (+0.28%)